|
ACHL
|
Achilles Therapeutics plc
|
US
|
NASDAQ
|
|
ADAP
|
Adaptimmune Therapeutics plc
|
US
|
NASDAQ
|
|
AGEN
|
Agenus Inc.
|
US
|
NASDAQ
|
|
AIM
|
AIM ImmunoTech Inc.
|
US
|
AMEX
|
|
ARWR
|
Arrowhead Research Corporation
|
US
|
NASDAQ
|
|
AURA
|
Aura Biosciences, Inc.
|
US
|
NASDAQ
|
|
BCAB
|
BioAtla, Inc.
|
US
|
NASDAQ
|
|
BFRI
|
Biofrontera Inc.
|
US
|
NASDAQ
|
|
BLCM
|
Bellicum Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
BMY
|
Bristol-Myers Squibb Company
|
US
|
NYSE
|
|
CSTL
|
Castle Biosciences, Inc.
|
US
|
NASDAQ
|
|
DCTH
|
Delcath Systems, Inc.
|
US
|
NASDAQ
|
|
DMTK
|
DermTech, Inc.
|
US
|
NASDAQ
|
|
EVAX
|
Evaxion Biotech A/S
|
US
|
NASDAQ
|
|
GALT
|
Galectin Therapeutics Inc.
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
ISR
|
IsoRay, Inc.
|
US
|
AMEX
|
|
KNTE
|
Kinnate Biopharma Inc.
|
US
|
NASDAQ
|
|
MYGN
|
Myriad Genetics, Inc.
|
US
|
NASDAQ
|
|
NAVB
|
Navidea Biopharmaceuticals, Inc.
|
US
|
AMEX
|